Companies · Fintech
Lagos · LA, Nigeria; LA, Nigeria · Fintech · founded 2022 · https://remedial.health
Diligence memoA one-page analyst read on Remedial Health — recommendation, valuation, rhythm, risks.→Remedial Health looks over-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the fintech sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Remedial Health is one of 1063 Fintech companies tracked from Lagos, LA, Nigeria; LA, Nigeria, on record since 2022. By capital raised it ranks in the upper tier (ahead of 84% of sector peers), and in the upper tier by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
B2B E-commerce & Fintech platform for Pharmacies & Hospitals in Africa
Remedial Health sells medicine wholesale to the 1 million pharmacies and hospitals in Africa. Today in Africa, pharmacies shop in open-air medicine markets where they pay higher prices for counterfeits medicines. We offer a managed marketplace with all the stock they'll need, deliver within 24 hours and offer credit to help them grow.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.
Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the fintech sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 1063 companies in Fintech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 84% of sector peers (real $). Modeled value above 84% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #7 of 53.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Floatpays Inc | Seed | $4.0M | $65.7M | 2.99× |
| Sote, Inc. | Seed | $11.3M | $65.5M | 2.98× |
| Earnipay | Seed | $4.0M | $63.7M | 2.90× |
| Pink Swan Trading, Inc. | Seed | $3.3M | $55.7M | 2.53× |
| Tweed Payments Inc. | Seed | $4.0M | $53.7M | 2.44× |
| Coverage Cat Inc. | Seed | $4.0M | $52.7M | 2.40× |
| Remedial Health this company | Seed | $4.4M | $52.7M | 2.40× |
| Duplo | Seed | $4.3M | $52.6M | 2.39× |
| Flash | Seed | $6.0M | $48.3M | 2.19× |
| Mobie Payments, Inc. | Seed | $3.0M | $47.0M | 2.14× |
| BluePenguin Payments Inc. | Seed | $3.2M | $45.5M | 2.07× |
| ImaliPay | Seed | $3.0M | $44.6M | 2.03× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Seed | $4.4M | 2022-09-21 | $22.0M | $52.7M | 45% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Remedial Health is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| SmartPath, Inc. | Fintech | Seed | $4.4M | $48.5M | same sector · same stage |
| Indicina, Inc. | Fintech | Seed | $4.5M | $73.6M | same sector · same stage |
| Duplo | Fintech | Seed | $4.3M | $52.6M | same sector · same stage |
| WealthForge Holdings, Inc. | Fintech | Seed | $4.1M | $7.2M | same sector · same stage |
| Coverage Cat Inc. | Fintech | Seed | $4.0M | $52.7M | same sector · same stage |
| Earnipay | Fintech | Seed | $4.0M | $63.7M | same sector · same stage |
| Floatpays Inc | Fintech | Seed | $4.0M | $65.7M | same sector · same stage |
| Kwara | Fintech | Seed | $4.0M | $70.0M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| ReEngage Therapeutics, Inc. | Pharma | Pre-Seed | $950K | 75% |
| Return Health Inc. | Pharmaceuticals | Pre-Seed | $3.1M | 75% |
| Reema Health Inc. | Healthtech | Series B | $93.1M | 74% |
| Suplias We enable FMCG distributors in Africa buy inventory on credit | Fintech | — | — | 74% |
| Africa Health Holdings Ltd | Hospitals and Physicians | Series A | $262.3M | 74% |
| Unstatiq Single source of truth for your clinic's finances and supply chain. | SaaS / Software | — | — | 73% |
| Abrexa Pharmaceuticals, Inc. | Biotech / Pharma | Series B | $118.0M | 73% |
| DBV Technologies S.A. | Pharmaceuticals | Series D+ | $2.6B | 73% |
See where Remedial Health sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Remedial Health, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.